H L Elliott|J R Lawrence - JoVE Visualize

Showing results (191-200 of 300) with videos related to

Pageof 30

Sort By:

European Journal of Clinical Pharmacology|January 1, 1993

The pharmacodynamics and pharmacokinetics of the combination of nifedipine and doxazosinR Donnelly, H L Elliott, P A Meredith, et al.

Journal of Molecular Endocrinology|August 1, 1996

Mistyping of the human angiotensin-converting enzyme gene polymorphism: frequency, causes and possible methods to avoid errors in typingS Ueda, R P Heeley, K R Lees, et al.

Journal of Cardiovascular Pharmacology|January 1, 1988

Factors determining the response to calcium antagonists in hypertensionR Donnelly, J L Reid, P A Meredith, et al.

Circulation|November 17, 1998

ACE (I/D) genotype as a predictor of the magnitude and duration of the response to an ACE inhibitor drug (enalaprilat) in humansS Ueda, P A Meredith, J J Morton, et al.

Microbial Ecology|August 3, 2002

Microscale evaluation of the effects of grazing by invertebrates with contrasting feeding modes on river biofilm architecture and compositionJ R Lawrence, B Scharf, G Packroff, et al.

British Journal of Clinical Pharmacology|January 1, 1979

Effect of acute alcohol intoxication on the metabolism and plasma kinetics of chlordiazepoxideB Whiting, J R Lawrence, G G Skellern, et al.

The Medical Journal of Australia|January 18, 1975

Acute interstitial nephritis following ampicillin hypersensitivityA J Woodroffe, M Weldon, R Meadows, et al.

British Journal of Clinical Pharmacology|July 1, 1991

Inhibitory effect of uraemia on the hepatic clearance and metabolism of nicardipineJ H Ahmed, A C Grant, R S Rodger, et al.

British Journal of Clinical Pharmacology|June 1, 1991

The effect of renal impairment on the pharmacokinetics and metabolism of bopindololN J MacDonald, A C Grant, R S Rodger, et al.

British Journal of Clinical Pharmacology|November 1, 1991

Studies with abanoquil (UK-52,046) a novel quinoline alpha 1-adrenoceptor antagonist: II. Duration of action, pharmacokinetics and concentration-effect relationships in normotensive subjectsR F Schafers, H L Elliott, P A Meredith, et al.

Pageof 30

Showing results (191-200 of 300) with videos related to

Sort By:

Pageof 30

European Journal of Clinical Pharmacology|January 1, 1993

The pharmacodynamics and pharmacokinetics of the combination of nifedipine and doxazosinR Donnelly, H L Elliott, P A Meredith, et al.

Journal of Molecular Endocrinology|August 1, 1996

Mistyping of the human angiotensin-converting enzyme gene polymorphism: frequency, causes and possible methods to avoid errors in typingS Ueda, R P Heeley, K R Lees, et al.

Journal of Cardiovascular Pharmacology|January 1, 1988

Factors determining the response to calcium antagonists in hypertensionR Donnelly, J L Reid, P A Meredith, et al.

Circulation|November 17, 1998

ACE (I/D) genotype as a predictor of the magnitude and duration of the response to an ACE inhibitor drug (enalaprilat) in humansS Ueda, P A Meredith, J J Morton, et al.

Microbial Ecology|August 3, 2002

Microscale evaluation of the effects of grazing by invertebrates with contrasting feeding modes on river biofilm architecture and compositionJ R Lawrence, B Scharf, G Packroff, et al.

British Journal of Clinical Pharmacology|January 1, 1979

Effect of acute alcohol intoxication on the metabolism and plasma kinetics of chlordiazepoxideB Whiting, J R Lawrence, G G Skellern, et al.

The Medical Journal of Australia|January 18, 1975

Acute interstitial nephritis following ampicillin hypersensitivityA J Woodroffe, M Weldon, R Meadows, et al.

British Journal of Clinical Pharmacology|July 1, 1991

Inhibitory effect of uraemia on the hepatic clearance and metabolism of nicardipineJ H Ahmed, A C Grant, R S Rodger, et al.

British Journal of Clinical Pharmacology|June 1, 1991

The effect of renal impairment on the pharmacokinetics and metabolism of bopindololN J MacDonald, A C Grant, R S Rodger, et al.

British Journal of Clinical Pharmacology|November 1, 1991

Studies with abanoquil (UK-52,046) a novel quinoline alpha 1-adrenoceptor antagonist: II. Duration of action, pharmacokinetics and concentration-effect relationships in normotensive subjectsR F Schafers, H L Elliott, P A Meredith, et al.

Pageof 30